Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence
Abstract
To evaluate the impact of botulinum toxin type A (BoNTA) on health-related quality of life in patients with neurogenic urinary incontinence (UI) using the Incontinence Quality of Life questionnaire (I-QOL).Randomized, double-blind, multicenter, placebo-controlled study involving eight centers across Belgium, France, and Switzerland. Patients (n = 59) with UI due to neurogenic detrusor overactivity (spinal cord injury, n = 53; multiple sclerosis,...
Paper Details
Title
Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence
Published Date
Sep 1, 2007
Journal
Volume
52
Issue
3
Pages
850 - 859
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History